$5.64
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
Overview
52-week range
$1.90
$11
43% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+0.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.38 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-7.30 | — | — | -362.0% | -9.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-5.76 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-6.42 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-1.58 | — | — | — | +9.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-153.20 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4049.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1020.48 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-54.14 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-51.86 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-2.59 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-5M | — | $-3M | $-2M | $-4M | — | $-6M |
| Net income | $-3M | $-5M | — | $-3M | $-2M | $-4M | — | $-6M |
| EPS (diluted) | $-0.38 | $-7.30 | — | $-5.76 | $-6.42 | $-18.93 | — | $-153.20 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $20M | $3M | $7M | $10M | $12M | $13M | $6M | $7M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $22M | $4M | $8M | $11M | $14M | $14M | $9M | $7M |
| Total assets | $22M | $5M | $9M | $12M | $15M | $14M | $9M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $5M | $4M | $2M | $1M | $3M | $3M | $4M |
| Total equity | $18M | $71,000 | $5M | $10M | $13M | $11M | $6M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for CNSP.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.